A new innovative product from AstraZeneca was launched in 4 different cities across Iraq, The US FDA Approved XigDue to treat type 2 diabetes was launched in both Erbil and Sulaymaniyah simultaneously on the 26th of May 2022, with another 2 cities launch in Nasiriya and Karbala a week after on the 3rd of June 2022.
Again, Progress Group couldn’t be prouder of our support to this launch to our client AstraZeneca in Iraq, the majority of the operations were handled by us including:
• Logistics support
• Media and Audio Systems
• LED Screen and projectors
• Printing facilitations
• Virtual Event Management, to name a few.
This turnkey event management was a part of many events we handled for AstraZeneca over the years and to other high end clients in Iraq.
Get in touch for any enquiries .Contact Us
